An Analysis of Construction Spending

in the Pharmaceutical & Biotech Industry, 2015-20

National Report

Overarching Stats

Total Construction Spending

Total Construction Spending

Total Construction Spending

Total Construction Spending

Total Construction Spending: 2015-2020, 14-State Total

Private-sector construction spending by the pharmaceutical and biotech industry increased every year across the 14-state area, starting at $3.9 billion in 2015 and increasing to $6.1 billion in 2020. A significant spike in private-sector investment occurred in 2019, effectively predating the COVID-19 pandemic. IIR estimates that industry construction spending will increase to $6.5 billion in 2021 and will remain above $5 billion annually through 2025.

Labor Hours by Trade (2015 – 2020)

The biopharmaceutical industry required 58.7 million labor hours from construction workers on facilities across 14 trades from 2015-2020.

Union Labor Hours: State Overview (2015 – 2020)

Union hours are estimated by multiplying the total number of labor hours demanded by each state’s union density in non-residential construction. The results show that the biopharmaceutical industry required a minimum of 22.3 million union labor hours to build and renovate facilities between 2015 and 2020.

Union Earnings: State Overview (2015 – 2020)

The biopharmaceutical industry required at least 22.3 million labor hours by union workers in the 14 states studied from 2015 – 2020. This yields a minimum of $774 million in worker earnings in addition to tens of millions of dollars in funding for union health insurance and pension benefits. The conservative nature of these estimates is due to statistical limitations - the full impact of the industry on union construction hours and earnings is likely to be substantially higher than projections.

Projects Overview: 2015-2020, 14-State Total

There were 447 major private-sector biopharmaceutical construction projects ($5M+) under construction at any point between 2015-2020. The report estimates these projects equated to $23.6 billion in industry investment in those 14 states.

Total Construction Spending

Total Construction Spending

Report

State by State

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers!

You may be surprised by the connection between the biopharmaceutical industry and union labor. A new study finds that from 2015-2020 America’s biopharmaceutical companies invested nearly $29 billion in infrastructure across 14 states creating thousands of jobs for union construction workers. Read the full report and see the state-by-state data here: https://bit.ly/2Syz1LO

America’s pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2015-2020 biopharmaceutical companies invested nearly $29 billion in infrastructure across 14 states creating thousands of jobs for union construction workers. Learn more and view the state-by-state data: https://bit.ly/2Syz1LO